A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer
CompletedOBSERVATIONAL
Enrollment
78
Participants
Timeline
Start Date
December 11, 2018
Primary Completion Date
May 31, 2022
Study Completion Date
June 30, 2024
Conditions
Breast Cancer
Interventions
DRUG
Ribociclib
combination of ribociclib and letrozole
Trial Locations (1)
B-3000
UZ Gasthuisberg Leuven, Leuven
All Listed Sponsors
lead
Universitaire Ziekenhuizen KU Leuven
OTHER
NCT03956654 - A Phase IV Study to Collect Data on the Efficacy and Safety of RIBociclib in Older Women With Breastcancer | Biotech Hunter | Biotech Hunter